» Authors » Koji Ichiyama

Koji Ichiyama

Explore the profile of Koji Ichiyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 574
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Preethy S, Sakamoto S, Higuchi T, Ichiyama K, Yamamoto N, Ikewaki N, et al.
Sci Rep . 2025 Feb; 15(1):7232. PMID: 40021828
Duchenne muscular dystrophy (DMD) is a rare genetic disease, causing muscle degeneration due to lack of dystrophin with inadequate muscle regeneration culminating in muscle dysfunction. The N-163 strain of Aureobasidium...
2.
Ikewaki N, Ichiyama K, Senthilkumar R, Preethy S, Abraham S
Front Public Health . 2025 Jan; 12():1495056. PMID: 39845678
No abstract available.
3.
Raghavan K, Sivakumar T, Ichiyama K, Yamamoto N, Balamurugan M, Dedeepiya V, et al.
Acta Myol . 2024 Feb; 42(4):129-134. PMID: 38406382
Background: Muscular dystrophies other than Duchenne muscular dystrophy (DMD) are genetic diseases characterized by increasing muscle weakness, loss of ambulation, and ultimately cardiac and respiratory failure. There are currently no...
4.
Kato F, Ishida Y, Oishi S, Fujii N, Watanabe S, Vasudevan S, et al.
Antiviral Res . 2016 May; 131:141-7. PMID: 27181378
Dengue virus (DENV) infectious disease is a major public health problem worldwide; however, licensed vaccines or specific antiviral drugs against this infection are not available. To identify novel anti-DENV compounds,...
5.
Muschin T, Budragchaa D, Kanamoto T, Nakashima H, Ichiyama K, Yamamoto N, et al.
Int J Biol Macromol . 2016 May; 89:415-20. PMID: 27154517
Naturally occurring galactomannans were sulfated to give sulfated galactomannans with degrees of substitution of 0.7-1.4 per sugar unit and molecular weights of M¯n=0.6×10(4)-2.4×10(4). Sulfated galactomannans were found to have specific...
6.
Tan D, Zhang L, Ohba K, Ye M, Ichiyama K, Yamamoto N
Eur J Immunol . 2016 Jan; 46(4):919-28. PMID: 26763072
Tumor-associated macrophages (TAMs) are known to regulate tumor response to many anti-cancer therapies, including oncolytic virotherapy. Oncolytic virotherapy employing oncolytic paramyxoviruses, such as attenuated measles (MeV) and mumps (MuV) viruses,...
7.
Suzuki Y, Chin W, Han Q, Ichiyama K, Lee C, Eyo Z, et al.
PLoS Pathog . 2016 Jan; 12(1):e1005357. PMID: 26735137
Dengue virus (DENV) is one of the most important arthropod-borne pathogens that cause life-threatening diseases in humans. However, no vaccine or specific antiviral is available for dengue. As seen in...
8.
Zhang L, Tan D, Jeyasekharan A, Hsieh W, Ho A, Ichiyama K, et al.
Cancer Lett . 2014 Sep; 354(2):272-80. PMID: 25193462
Through combining vaccine-derived measles and mumps viruses (MM), we efficiently targeted a wide range of hematopoietic cancer cell lines. MM synergistically killed many cell lines including acute myeloid leukemia (AML)...
9.
Ohba K, Ichiyama K, Yajima M, Gemma N, Nikaido M, Wu Q, et al.
PLoS One . 2014 May; 9(5):e97787. PMID: 24858917
High prevalence of infection with high-risk human papilloma virus (HPV) ranging from 25 to 100% (average 31%) was observed in breast cancer (BC) patients in Singapore using novel DNA chip...
10.
He H, Sharer L, Chao W, Gu C, Borjabad A, Hadas E, et al.
J Neuropathol Exp Neurol . 2013 Dec; 73(1):59-71. PMID: 24335529
The roles of Type I interferon (IFN) in human immunodeficiency virus Type 1 (HIV-1) neuropathogenesis are poorly understood; both protective and deleterious effects of IFN signaling have been described. We...